Discovery & Development

Ewoud van Tricht explores three novel methods that could streamline the development of adenovirus vaccines for COVID-19 at Janssen.

Exploring the role of the gut microbiome on immunotherapy.

We find out the story behind the Baylor College of Medicine Center for Space Medicine.

Sanofi and DNDi are co-developing a drug – acoziborole – to treat sleeping sickness.

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

What biosecurity risks do exo-microorganisms pose?

Ross Burn presents the story behind his career, including setting up a company on process chemistry and his views on industry 4.0.

Implementing green practices in clinical trials.

Oligonucleotide-based therapeutics present manufacturers with specific processing and characterization challenges.

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.